fda bpc-157 unapproved new drug panel votes to place popular peptide on compounding list Important Update on FDA Changes

BPC-157 simply provides the right signals

If your baseline B12 is already adequate, MIC B12 injections target metabolic support rather than deficiency correction, making proper storage even more critical for consistent benefit

In some rare cases, very high levels of B12 in the blood can be associated with minor side effects like mild acne, dizziness, or a temporary rash

And naturally, the internet is treating it like a miracle skinny shot or a dangerous science experiment

The TRIUMPH-4 Phase 3 data provides the most current safety information: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) versus 0% placebo Decreased appetite: 19.0% (9 mg) to 18.2% (12 mg) versus 9.4% placebo The pattern is clear

Currently I am on week three of my first month of Tirzeptide and notice a significant difference in my food cravings and hunger